Feng-Cheng Chang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Feng-Cheng Chang has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Shao-Wei Chen
Division of Thoracic and Cardiovascular Surgery, Department of Surgery, Chang Gung Memorial Hospital, Linkou Medical Center, Chang Gung University, Taoyuan City, Taiwan; Center for Big Data Analytics and Statistics, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan City, Taiwan
13 shared publications Yu-Ting Cheng
Division of Thoracic and Cardiovascular Surgery, Department of Surgery, Chang Gung Memorial Hospital, Linkou Medical Center, Chang Gung University, Taoyuan, Taiwan
10 shared publicationsChun-Yu Chen
Department of Anesthesiology, Chang Gung Memorial Hospital, Linkou Medical Center, Chang Gung University, Taoyuan, Taiwan
8 shared publicationsChia-Pin Lin
Department of Cardiology, Chang Gung Memorial Hospital, Linkou Medical Center, Chang Gung University, Taoyuan, Taiwan
6 shared publications- Pao-Hsien Chu
Chang Gung Memorial Hospital
6 shared publications - Victor Chien-Chia Wu
Division of Cardiology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan City, Taiwan
5 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 19, 1-12
Heart Failure Pharmacotherapy and Long-Term Outcomes After Extracorporeal Membrane Oxygenation: A Nationwide Real-World Cohort Study
Objective: We examined prescription trends and associations between post-discharge heart failure (HF) guideline-directed medical therapy (GDMT) and long-term outcomes in patients with cardiogenic extracorporeal membrane oxygenation (ECMO), a population with limited evidence on long-term management. Methods: This nationwide retrospective observational cohort used Taiwan’s real-world National Health Insurance Research Database. Adults undergoing cardiogenic ECMO during 2011– 2023 who survived at least 6 months after discharge were included. Qualifying exposure required at least 28 cumulative prescription days during the first 6 months after discharge. Follow-up began at the 6-month landmark and continued through December 31, 2024. Associations were estimated using stabilized inverse probability of treatment weighting; propensity score matching served as a sensitivity analysis. Results: Among 4,428 patients, 3,164 received qualifying HF pharmacotherapy and 1,264 did not. Use shifted from angiotensin-converting enzyme inhibitors and digoxin toward angiotensin receptor blockers, beta-blockers, sodium-glucose cotransporter 2 inhibitors, and ivabradine. HF medication use was associated with lower all-cause mortality (HR, 0.57; 95% CI, 0.51– 0.65), the composite of cardiovascular death or HF hospitalization (HR, 0.77; 95% CI, 0.65– 0.92), and cardiovascular death (HR, 0.65; 95% CI, 0.53– 0.79). Renin-angiotensin system inhibitors and beta-blockers were each associated with lower mortality (HR, 0.69; 95% CI, 0.61– 0.78). Sensitivity analyses were consistent. Conclusion: Among 6-month survivors of cardiogenic ECMO, a high-risk and clinically unique population often excluded from HF trials, post-discharge HF pharmacotherapy was associated with lower long-term mortality. These findings support structured cardiovascular reassessment and individualized HF medication review after ECMO.
- 1 September 2026
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 19, 1-12
Open AccessHeart Failure Pharmacotherapy and Long-Term Outcomes After Extracorporeal Membrane Oxygenation: A Nationwide Real-World Cohort Study
Objective: We examined prescription trends and associations between post-discharge heart failure (HF) guideline-directed medical therapy (GDMT) and long-term outcomes in patients with cardiogenic extracorporeal membrane oxygenation (ECMO), a population with limited evidence on long-term management. Methods: This nationwide retrospective observational cohort used Taiwan’s real-world National Health Insurance Research Database. Adults undergoing cardiogenic ECMO during 2011– 2023 who survived at least 6 months after discharge were included. Qualifying exposure required at least 28 cumulative prescription days during the first 6 months after discharge. Follow-up began at the 6-month landmark and continued through December 31, 2024. Associations were estimated using stabilized inverse probability of treatment weighting; propensity score matching served as a sensitivity analysis. Results: Among 4,428 patients, 3,164 received qualifying HF pharmacotherapy and 1,264 did not. Use shifted from angiotensin-converting enzyme inhibitors and digoxin toward angiotensin receptor blockers, beta-blockers, sodium-glucose cotransporter 2 inhibitors, and ivabradine. HF medication use was associated with lower all-cause mortality (HR, 0.57; 95% CI, 0.51– 0.65), the composite of cardiovascular death or HF hospitalization (HR, 0.77; 95% CI, 0.65– 0.92), and cardiovascular death (HR, 0.65; 95% CI, 0.53– 0.79). Renin-angiotensin system inhibitors and beta-blockers were each associated with lower mortality (HR, 0.69; 95% CI, 0.61– 0.78). Sensitivity analyses were consistent. Conclusion: Among 6-month survivors of cardiogenic ECMO, a high-risk and clinically unique population often excluded from HF trials, post-discharge HF pharmacotherapy was associated with lower long-term mortality. These findings support structured cardiovascular reassessment and individualized HF medication review after ECMO.
- 20 July 2026
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 84 (2) , 555-556
Positron emission tomography-guided planning is associated with improved outcomes after thoracic endovascular aortic repair in T4b esophageal cancer
- 20 July 2026
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 84 (2) , 555-556
Positron emission tomography-guided planning is associated with improved outcomes after thoracic endovascular aortic repair in T4b esophageal cancer
Maternal and neonatal outcomes in Marfan syndrome: a nationwide registry
Background: Pregnancy in women with Marfan syndrome (MFS) is associated with increased maternal and neonatal risks, yet most existing studies are limited by small sample sizes and short follow-up. This study aimed to evaluate peripartum and long-term maternal outcomes, as well as neonatal outcomes, in MFS pregnancies using nationwide data from Taiwan. Methods: This population-based cohort study analysed pregnancies identified from national health databases in Taiwan between 2004 and 2022. Maternal outcomes included severe aortic complications, 42-day and late maternal mortality and long-term cardiovascular events. Neonatal outcomes comprised gestational age, birth weight and neonatal complications. Logistic and Poisson regression models were used to estimate adjusted ORs and incidence rate ratio (IRR). Results: Among 3 337 969 pregnancies (2 073 560 women), 794 pregnancies in 500 women with MFS were identified. Compared with non-MFS pregnancies, those with MFS had markedly higher rates of severe aortic complications (1.1% vs 0.0005%) and 42-day maternal mortality (0.1% vs 0.02%). During a mean 10.7-year follow-up, the risks of composite aortic events (IRR 885.4, 95% CI 629.3 to 1245.6) and late maternal mortality (IRR 5.1, 95% CI 3.1 to 8.7) remained significantly elevated. Neonates born to mothers with MFS had lower gestational age and birth weight and higher risks of neonatal complications requiring intensive care. Conclusions: MFS pregnancies carry high risks of aortic complications and maternal mortality, persisting into long-term follow-up. Neonatal outcomes are also adversely affected. Early diagnosis, preconception counselling and multidisciplinary, guideline-adherent care are essential to optimise maternal and neonatal safety and long-term outcomes.
Maternal and neonatal outcomes in Marfan syndrome: a nationwide registry
Background: Pregnancy in women with Marfan syndrome (MFS) is associated with increased maternal and neonatal risks, yet most existing studies are limited by small sample sizes and short follow-up. This study aimed to evaluate peripartum and long-term maternal outcomes, as well as neonatal outcomes, in MFS pregnancies using nationwide data from Taiwan. Methods: This population-based cohort study analysed pregnancies identified from national health databases in Taiwan between 2004 and 2022. Maternal outcomes included severe aortic complications, 42-day and late maternal mortality and long-term cardiovascular events. Neonatal outcomes comprised gestational age, birth weight and neonatal complications. Logistic and Poisson regression models were used to estimate adjusted ORs and incidence rate ratio (IRR). Results: Among 3 337 969 pregnancies (2 073 560 women), 794 pregnancies in 500 women with MFS were identified. Compared with non-MFS pregnancies, those with MFS had markedly higher rates of severe aortic complications (1.1% vs 0.0005%) and 42-day maternal mortality (0.1% vs 0.02%). During a mean 10.7-year follow-up, the risks of composite aortic events (IRR 885.4, 95% CI 629.3 to 1245.6) and late maternal mortality (IRR 5.1, 95% CI 3.1 to 8.7) remained significantly elevated. Neonates born to mothers with MFS had lower gestational age and birth weight and higher risks of neonatal complications requiring intensive care. Conclusions: MFS pregnancies carry high risks of aortic complications and maternal mortality, persisting into long-term follow-up. Neonatal outcomes are also adversely affected. Early diagnosis, preconception counselling and multidisciplinary, guideline-adherent care are essential to optimise maternal and neonatal safety and long-term outcomes.
- 25 November 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (10) , 1264-1265
Beyond boundaries: towards a global understanding of infected native aortic aneurysms
- 25 November 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (10) , 1264-1265
Beyond boundaries: towards a global understanding of infected native aortic aneurysms
- 15 October 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 46 (45) , 5011-5012
Beyond the immediate light: reappraising open surgery for long-term outcomes in infected native aortic aneurysms
- 15 October 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 46 (45) , 5011-5012
Beyond the immediate light: reappraising open surgery for long-term outcomes in infected native aortic aneurysms
- Open Access
- 2 September 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (17) , e041724
Outcomes of End Stage Renal Disease in Patients With Infective Endocarditis: A Nationwide Population‐Based Study
Background: Infective endocarditis (IE) is a serious and potentially lethal condition in patients with end‐stage renal disease (ESRD). This study aimed to describe the clinical features, provide epidemiology information, and compare short and long‐term outcomes of IE in patients with ESRD. Methods: Patients who were admitted due to IE from 2001 to 2021 were identified from Taiwan's National Health Insurance Research Database and grouped based on whether they were undergoing chronic dialysis with ESRD. Primary outcomes were surgical rate during the index IE hospitalization, in‐hospital death, and all‐cause death after surviving to discharge. Results: A total of 27 336 patients were included, with 3258 (11.9%) receiving dialysis. The surgical rate significantly increased over years in both the groups with and without ESRD. In‐hospital and late mortalities were significantly higher in patients with ESRD (32.9% versus 16.9%, and 76.0% versus 48.1%, respectively). The predominant pathogen was methicillin‐resistant Staphylococcus aureus , significantly higher in patients with ESRD (56.7% versus 32.8%). The vintage, type of hemodialysis access (tunnels, grafts, or fistulas), and initial dialysis modality were not correlated to the risk of in‐hospital mortality of patients with IE with ESRD. Patients who received valve surgery had better long‐term survival than those who did not receive in either the groups with and without ESRD and non‐ESRD. Conclusions: Patients with ESRD have higher in‐hospital and late mortality rates, more complications, and a higher recurrence rate of IE than patients without ESRD. The long‐term survival rates were higher in both the groups with and without ESRD and non‐ESRD who underwent surgeries for IE; therefore, surgery may be considered if the patient's condition permits.
- 2 September 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (17) , e041724
Open AccessOutcomes of End Stage Renal Disease in Patients With Infective Endocarditis: A Nationwide Population‐Based Study
Background: Infective endocarditis (IE) is a serious and potentially lethal condition in patients with end‐stage renal disease (ESRD). This study aimed to describe the clinical features, provide epidemiology information, and compare short and long‐term outcomes of IE in patients with ESRD. Methods: Patients who were admitted due to IE from 2001 to 2021 were identified from Taiwan's National Health Insurance Research Database and grouped based on whether they were undergoing chronic dialysis with ESRD. Primary outcomes were surgical rate during the index IE hospitalization, in‐hospital death, and all‐cause death after surviving to discharge. Results: A total of 27 336 patients were included, with 3258 (11.9%) receiving dialysis. The surgical rate significantly increased over years in both the groups with and without ESRD. In‐hospital and late mortalities were significantly higher in patients with ESRD (32.9% versus 16.9%, and 76.0% versus 48.1%, respectively). The predominant pathogen was methicillin‐resistant Staphylococcus aureus , significantly higher in patients with ESRD (56.7% versus 32.8%). The vintage, type of hemodialysis access (tunnels, grafts, or fistulas), and initial dialysis modality were not correlated to the risk of in‐hospital mortality of patients with IE with ESRD. Patients who received valve surgery had better long‐term survival than those who did not receive in either the groups with and without ESRD and non‐ESRD. Conclusions: Patients with ESRD have higher in‐hospital and late mortality rates, more complications, and a higher recurrence rate of IE than patients without ESRD. The long‐term survival rates were higher in both the groups with and without ESRD and non‐ESRD who underwent surgeries for IE; therefore, surgery may be considered if the patient's condition permits.
- Open Access
- 31 July 2025
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 12 (8)
Sex Differences in Clinical Outcomes and Surgical Interventions for Infective Endocarditis: A Nationwide Registry
Background: Sex differences in infective endocarditis (IE) remain underexplored in large-scale studies. Current findings on clinical outcomes, particularly in surgical IE, are inconsistent, highlighting critical knowledge gaps. Methods: We conducted a nationwide cohort study using the Taiwan National Health Insurance Research Database (2001–2022) and a total of 28 976 adults with IE were identified. Subgroup analysis focused on 4133 patients undergoing valve surgery. Primary outcomes included in-hospital mortality and long-term survival, analyzed using logistic regression and Cox models. Results: Of 28 976 patients, 4133 underwent surgery (women/men: 10 580/18 396 overall; 1252/2881 surgical). Women were older with more comorbidities. After propensity score matching, women had higher in-hospital mortality in both the general cohort (21.2% vs 19.8%; odds ratio [OR]: 1.09, 95% confidence interval [CI]: 1.02–1.17) and surgical subgroup (20.7% vs 13.3%; OR: 1.70, 95% CI: 1.37–2.11). Women undergoing surgery had more perioperative complications, including postcardiotomy cardiogenic shock (10.5% vs 7.8%) and de novo dialysis (13.5% vs 9.8%). Long-term mortality was lower in women, while women in the surgical subgroup had higher mortality (hazard ratio [HR]: 1.12, 95% CI: 1.01–1.25) and redo valve surgery rates (11.5% vs 8.1%; HR: 1.43; 95% CI: 1.07–1.90). Conclusions: Women with IE had higher in-hospital mortality regardless of surgical intervention. Among those who underwent surgery, women experienced more perioperative complications compared with men. Although women exhibited superior overall late survival, those undergoing surgery had worse long-term outcomes. These findings highlight the need for improved sex-specific management, including early diagnosis, timely surgery, and extended follow-up.
- 31 July 2025
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 12 (8)
Open AccessSex Differences in Clinical Outcomes and Surgical Interventions for Infective Endocarditis: A Nationwide Registry
Background: Sex differences in infective endocarditis (IE) remain underexplored in large-scale studies. Current findings on clinical outcomes, particularly in surgical IE, are inconsistent, highlighting critical knowledge gaps. Methods: We conducted a nationwide cohort study using the Taiwan National Health Insurance Research Database (2001–2022) and a total of 28 976 adults with IE were identified. Subgroup analysis focused on 4133 patients undergoing valve surgery. Primary outcomes included in-hospital mortality and long-term survival, analyzed using logistic regression and Cox models. Results: Of 28 976 patients, 4133 underwent surgery (women/men: 10 580/18 396 overall; 1252/2881 surgical). Women were older with more comorbidities. After propensity score matching, women had higher in-hospital mortality in both the general cohort (21.2% vs 19.8%; odds ratio [OR]: 1.09, 95% confidence interval [CI]: 1.02–1.17) and surgical subgroup (20.7% vs 13.3%; OR: 1.70, 95% CI: 1.37–2.11). Women undergoing surgery had more perioperative complications, including postcardiotomy cardiogenic shock (10.5% vs 7.8%) and de novo dialysis (13.5% vs 9.8%). Long-term mortality was lower in women, while women in the surgical subgroup had higher mortality (hazard ratio [HR]: 1.12, 95% CI: 1.01–1.25) and redo valve surgery rates (11.5% vs 8.1%; HR: 1.43; 95% CI: 1.07–1.90). Conclusions: Women with IE had higher in-hospital mortality regardless of surgical intervention. Among those who underwent surgery, women experienced more perioperative complications compared with men. Although women exhibited superior overall late survival, those undergoing surgery had worse long-term outcomes. These findings highlight the need for improved sex-specific management, including early diagnosis, timely surgery, and extended follow-up.
- 11 July 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (20) , 2466-2477
Infected native aortic aneurysms: epidemiology, management, and outcomes based on a nationwide population-based study
Background and Aims: Large-scale investigations with longitudinal data on infected native aortic aneurysms (INAAs), a rare but life-threatening emergency, are lacking. The epidemiology, treatment trends, and outcomes of INAAs were investigated in a nationwide population-based cohort. Methods: A total of 2387 hospitalisations for INAAs were identified between 2001 and 2021 in the Taiwanese National Health Insurance Research Database. A retrospective cohort was analysed using data spanning a 21-year study period. In-hospital and post-discharge adverse events, including 1-, 3-, 5- and 10-year mortality, were assessed. Results: The cohort had a mean age of 73.8 ± 11.8 years, with 77.6% being men. There was an increasing trend in INAAs over time, with a high prevalence of comorbid renal insufficiency (53%). Most patients were treated with third-generation cephalosporins and anti-methicillin-resistant Staphylococcus aureus agents. Conservative treatment was associated with the highest mortality rates, including in-hospital death and post-discharge death. The risk of in-hospital mortality was significantly lower in the endovascular aortic repair (EVAR) group compared with the open repair group [odds ratio 0.76, 95% confidence interval (CI): 0.63–0.91]. At the end of follow-up, patients who underwent EVAR demonstrated high mortality risks (hazard ratio 1.13, 95% CI: 1.04–1.23 at the end of follow-up) than open repair. Conclusions: Surgical repair is associated with significantly more favourable post-discharge survival compared with EVAR, underscoring the importance of open repair for optimal management of INAAs. In selected high-risk patients, EVAR may serve as a temporising or palliative option, particularly when definitive open repair is not immediately feasible.
- 11 July 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (20) , 2466-2477
Infected native aortic aneurysms: epidemiology, management, and outcomes based on a nationwide population-based study
Background and Aims: Large-scale investigations with longitudinal data on infected native aortic aneurysms (INAAs), a rare but life-threatening emergency, are lacking. The epidemiology, treatment trends, and outcomes of INAAs were investigated in a nationwide population-based cohort. Methods: A total of 2387 hospitalisations for INAAs were identified between 2001 and 2021 in the Taiwanese National Health Insurance Research Database. A retrospective cohort was analysed using data spanning a 21-year study period. In-hospital and post-discharge adverse events, including 1-, 3-, 5- and 10-year mortality, were assessed. Results: The cohort had a mean age of 73.8 ± 11.8 years, with 77.6% being men. There was an increasing trend in INAAs over time, with a high prevalence of comorbid renal insufficiency (53%). Most patients were treated with third-generation cephalosporins and anti-methicillin-resistant Staphylococcus aureus agents. Conservative treatment was associated with the highest mortality rates, including in-hospital death and post-discharge death. The risk of in-hospital mortality was significantly lower in the endovascular aortic repair (EVAR) group compared with the open repair group [odds ratio 0.76, 95% confidence interval (CI): 0.63–0.91]. At the end of follow-up, patients who underwent EVAR demonstrated high mortality risks (hazard ratio 1.13, 95% CI: 1.04–1.23 at the end of follow-up) than open repair. Conclusions: Surgical repair is associated with significantly more favourable post-discharge survival compared with EVAR, underscoring the importance of open repair for optimal management of INAAs. In selected high-risk patients, EVAR may serve as a temporising or palliative option, particularly when definitive open repair is not immediately feasible.
- Open Access
- 7 July 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 71 (4) , 586-594
Outcomes of Frozen Elephant Trunk for Type A Acute Aortic Dissection: A Nationwide, Population Based Study
- 7 July 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 71 (4) , 586-594
Open AccessOutcomes of Frozen Elephant Trunk for Type A Acute Aortic Dissection: A Nationwide, Population Based Study